Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Chapman

Showing results (181-190 of 345) with videos related to

Pageof 35
Sort By:
Clinical Pharmacology and Therapeutics|July 29, 2011
Relationship between serum urate and plasma oxypurinol in the management of gout: determination of minimum plasma oxypurinol concentration to achieve a target serum urate levelL K Stamp, M L Barclay, J L O'Donnell, et al.
The Journal of Rheumatology|October 4, 2011
Effects of changing from oral to subcutaneous methotrexate on red blood cell methotrexate polyglutamate concentrations and disease activity in patients with rheumatoid arthritisLisa K Stamp, Murray L Barclay, John L O'Donnell, et al.
Physical Review Letters|January 15, 2011
Magnetic reconnection triggering magnetohydrodynamic instabilities during a sawtooth crash in a Tokamak plasmaI T Chapman, R Scannell, W A Cooper, et al.
Journal of Hand Therapy : Official Journal of the American Society of Hand Therapists|April 26, 2008
Combat casualty hand burns: evaluating impairment and disability during recoveryTed T Chapman, Reg L Richard, Travis L Hedman, et al.
Annals of the Rheumatic Diseases|August 24, 2017
Allopurinol dose escalation to achieve serum urate below 6 mg/dL: an open-label extension studyLisa K Stamp, Peter T Chapman, Murray Barclay, et al.
Rheumatology (Oxford, England)|April 28, 2012
Furosemide increases plasma oxypurinol without lowering serum urate--a complex drug interaction: implications for clinical practiceLisa K Stamp, Murray L Barclay, John L O'Donnell, et al.
Frontiers in Medicine|December 9, 2022
Giant cell arteritis: A population-based retrospective cohort study exploring incidence and clinical presentation in Canterbury, Aotearoa New ZealandSuellen A Lyne, Carlee Ruediger, Susan Lester, et al.
Arthritis and Rheumatism|February 1, 2011
Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairmentLisa K Stamp, John L O'Donnell, Mei Zhang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1994
Imaging vascular endothelial activation: an approach using radiolabeled monoclonal antibodies against the endothelial cell adhesion molecule E-selectinE T Keelan, A A Harrison, P T Chapman, et al.
Arthritis Research & Therapy|November 25, 2015
Association between environmental exposures and granulomatosis with polyangiitis in Canterbury, New ZealandLisa K Stamp, Peter T Chapman, Janine Francis, et al.
Pageof 35

Showing results (181-190 of 345) with videos related to

Sort By:
Pageof 35
Clinical Pharmacology and Therapeutics|July 29, 2011
Relationship between serum urate and plasma oxypurinol in the management of gout: determination of minimum plasma oxypurinol concentration to achieve a target serum urate levelL K Stamp, M L Barclay, J L O'Donnell, et al.
The Journal of Rheumatology|October 4, 2011
Effects of changing from oral to subcutaneous methotrexate on red blood cell methotrexate polyglutamate concentrations and disease activity in patients with rheumatoid arthritisLisa K Stamp, Murray L Barclay, John L O'Donnell, et al.
Physical Review Letters|January 15, 2011
Magnetic reconnection triggering magnetohydrodynamic instabilities during a sawtooth crash in a Tokamak plasmaI T Chapman, R Scannell, W A Cooper, et al.
Journal of Hand Therapy : Official Journal of the American Society of Hand Therapists|April 26, 2008
Combat casualty hand burns: evaluating impairment and disability during recoveryTed T Chapman, Reg L Richard, Travis L Hedman, et al.
Annals of the Rheumatic Diseases|August 24, 2017
Allopurinol dose escalation to achieve serum urate below 6 mg/dL: an open-label extension studyLisa K Stamp, Peter T Chapman, Murray Barclay, et al.
Rheumatology (Oxford, England)|April 28, 2012
Furosemide increases plasma oxypurinol without lowering serum urate--a complex drug interaction: implications for clinical practiceLisa K Stamp, Murray L Barclay, John L O'Donnell, et al.
Frontiers in Medicine|December 9, 2022
Giant cell arteritis: A population-based retrospective cohort study exploring incidence and clinical presentation in Canterbury, Aotearoa New ZealandSuellen A Lyne, Carlee Ruediger, Susan Lester, et al.
Arthritis and Rheumatism|February 1, 2011
Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairmentLisa K Stamp, John L O'Donnell, Mei Zhang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1994
Imaging vascular endothelial activation: an approach using radiolabeled monoclonal antibodies against the endothelial cell adhesion molecule E-selectinE T Keelan, A A Harrison, P T Chapman, et al.
Arthritis Research & Therapy|November 25, 2015
Association between environmental exposures and granulomatosis with polyangiitis in Canterbury, New ZealandLisa K Stamp, Peter T Chapman, Janine Francis, et al.
Pageof 35